NASA considers SANS one of its ‘red risks’ for a Mars mission, owing to its potential severity and the number of astronauts ...
An experimental stem cell therapy reversed corneal damage in half of the participants from a recent clinical trial.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback